| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.003 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.009 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-11 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.24 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |